To help companies improve their preventive care for employees, C-Change, a national cancer coalition of government, business, and nonprofit leaders, has launched the “Making the Business Case for Cancer Prevention & Early Detection” campaign.
To launch the campaign, the organization has issued a white paper based on growing evidence that it is more costly to pay for cancer treatment than to provide early detection and prevention measures.
Significant financial savings can be achieved by implementing four proven cost-effective cancer prevention measures: smoking cessation programs; and screening for breast, colorectal, and cervical cancers, the paper notes. For example, one study showed that an investment of $2.95 per employee per month to reach near full compliance for breast, colorectal, and cervical cancer screening could yield savings of up to $3.75 per month.
The White Paper can be accessed on www.c-changeprojects.org/makingthebusinesscase/